| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Baynes Roy D. is a Director at ATRA with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $7.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | NTRA Natera, Inc. | Director | Sale+OE | 12,780 | $219.85 | $2,809,688.61 | -7.0% | -4.4% | - | |
| Feb 6, 2025 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 10,000 | $22.00 | $220,000.00 | -24.4% | -7.5% | +35.9% | |
| Jan 23, 2025 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 16,000 | $20.00 | $320,000.00 | -34.0% | -19.8% | +41.5% | |
| Nov 15, 2024 | NTRA Natera, Inc. | Director | Sale+OE | 37,230 | $146.11 | $5,439,564.61 | -18.7% | +16.9% | +39.9% |